Literature DB >> 12187858

[Epidemiology of atrial fibrillation].

Stefan Sack1.   

Abstract

FREQUENCY: Atrial fibrillation is the most frequent sustained arrhythmia, especially in the elderly. The incidence accounts for 2% past the age of 40 years, 6% over 70, an approximately 15% over 90 years old. PATHOGENESIS: Primary cause in "idiopathic" atrial fibrillation is differentiated from secondary causes of cardiac and non-cardiac origin. Important predictive cardiovascular diseases to develop atrial fibrillation are coronary heart disease, hypertension or rheumatic heart disease. Electrophysiological mechanism behind atrial fibrillation is a reentry circuit. The clinical symptoms are influenced by the conducted ventricular heart rate and the loss of atrial contraction. TREATMENT AND PROGNOSIS: The need for a therapeutic approach--either for recurrence of sinus rhythm or heart rate control--is mainly determined by the quality of life. Quality of life, functional capacity and maximum oxygen consumption are improved if sinus rhythm is reestablished. Finally, mortality is double as high if atrial fibrillation is present. Whether mortality is directly influenced by atrial fibrillation or fibrillation is considered as more or less the subsequent arrhythmia for an underlying disease is still under investigation.

Entities:  

Mesh:

Year:  2002        PMID: 12187858     DOI: 10.1007/s00059-002-2395-2

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  4 in total

1.  [Patients suffering from atrial fibrillation in Germany. Characteristics, resource consumption and costs].

Authors:  T Reinhold; S Rosenfeld; F Müller-Riemenschneider; S N Willich; T Meinertz; P Kirchhof; B Brüggenjürgen
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

Review 2.  Atrial fibrillation: established and innovative methods of evaluation and treatment.

Authors:  Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

3.  [Surgical atrial fibrillation ablation therapy and postoperative monitoring].

Authors:  T Hanke; H-H Sievers
Journal:  Herz       Date:  2011-12       Impact factor: 1.443

Review 4.  Atrial fibrillation: profit from cardiac pacing?

Authors:  A Yang; B Lüderitz; T Lewalter
Journal:  Z Kardiol       Date:  2005-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.